+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-10-16Number of Pages: 170

Cellular Health Screening Market (Test Type - Telomere Tests, Oxidative Stress Tests, Inflammation Tests, Heavy Metal Tests, Multi-test Panels; Sample Type - Blood, Body Fluids) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022

Global Cellular Health Screening Market: Snapshot

The report provides a comprehensive look at the global cellular health screening market for readers with the help of detailed historical information and solid, industry-standard analytical techniques. The global cellular health screening market has risen at a robust pace in recent years thanks to a growing focus on healthcare among the geriatric population and the steady development of the healthcare sector. The global cellular health screening market is likely to rise in developed regions at a robust pace in the coming years, with North America likely to dominate the global market in the coming years. The cellular health screening market has benefited from the growing focus on comprehensive and preventative healthcare across the world and is likely to exhibit steady growth at a strong 8% CAGR over the 2017-2022 forecast period.

According to Transparency Market Research, the global cellular health screening market is expected to rise to a valuation of US$2.1 bn by the end of 2017 and further rise to more than US$3.1 bn by the end of 2022.

cellular health screening market

 

Telomere Tests Likely to Remain Dominant Test Type in Cellular Health Screening Market

By test type, the global cellular health screening market is segmented into telomere tests, oxidative stress tests, inflammation tests, heavy metal tests, and multi-test panels. Of these, telomere tests are likely to remain the dominant test type in the global cellular health screening market in the coming years. Telomere tests are vital in understanding the effects of aging on an individual’s body, which is likely to drive their demand in the coming years at a robust rate. Telomere tests accounted for 35% of the global cellular health screening market in 2017 with a valuation of US$744.1 mn. Exhibiting a robust 8.4% CAGR, the telomere tests segment is expected to rise to a valuation of US$1,111.8 mn over the 2017-2022 forecast period. The share of the telomere tests segment is likely to rise from 35% to 35.6% over the 2017-2022 forecast period.

North America, Europe to Remain Dominant Contributors to Cellular Health Screening Market

The report looks into the performance of the cellular health screening market in North America, Latin America, Europe, Asia Pacific except Japan, Japan, and the Middle East and Africa in order to understand the regional dynamics of the global market. North America is likely to remain the leading contributor to the global cellular health screening market in the coming years due to the steady growth of the healthcare sector in the region. The North America cellular health screening market is likely to be valued at US$883.2 mn by the end of 2017 and further rise to a valuation of US$1,317 mn by the end of 2022 at an 8.3% CAGR over the 2017-2022 forecast period.

Europe is also likely to exhibit a strong 7.5% CAGR over the 2017-2022 forecast period to rise to a valuation of US$754.8 mn by 2022.

Asia Pacific except Japan to Exhibit Highest 8.5% CAGR

The Asia Pacific except Japan market for cellular health screening is a promising regional segment for players looking to dominate the global cellular health screening market in the coming years. The APEJ cellular health screening market is likely to exhibit an 8.5% CAGR over the 2017-2022 forecast period to rise to a 2022 valuation of US$522 mn.

Global Cellular Health Screening Market: Competitive Dynamics

Leading players in the global cellular health screening market include Quest Diagnostics Incorporated, Bio-Reference Laboratories Inc., Cell Science Systems Corporation, Cleveland HeartLab Inc., Genova Diagnostics Inc., Laboratory Corporation of America Holdings, Life Length S.L., and SpectraCell Laboratories Inc.

Global Cellular Health Screening Market: Overview

The global cellular health screening market report provides readers with a comprehensive understanding of the development prospects of the market in the coming years with the help of solid historical information illustrating the past growth trajectory of the cellular health screening market. Latest figures of the global cellular health screening market are provided in the report in order to acquaint readers with the structure and composition of the market’s most recent position. The growth trajectory of the cellular health screening market from 2012 to 2017 is assessed in the report in order to provide analysts with a solid foundation for 2017-2022 forecasts regarding the likely growth of the cellular health screening market.

The global cellular health screening market is likely to reach a valuation of US$2.1 bn by the end of 2017. According to Transparency Market Research, the global cellular health screening market is expected to exhibit a strong 8% CAGR between 2017 and 2022 to rise to a valuation of US$3.1 bn.

Global Cellular Health Screening Market: Dynamics

The key drivers and restraints determining the growth prospects of the global cellular health screening market are assessed in the report to help readers understand which factors are likely to aid and hinder their growth prospects in the cellular health screening market in the coming years. The cellular health screening market is affected by a number of factors determining the development of the healthcare sector across the world both positively and negatively. The report provides a detailed look into the extent of the effect each factor is likely to have on the global cellular health screening market in the coming years, illustrating the interrelation between the growth trajectory of the cellular health screening market and the various factors affecting it in the coming years.

Global Cellular Health Screening Market: Segmentation

The report takes a close look at the leading segments of the global cellular health screening market in order to familiarize with the leading revenue generators in the market. The 2012-2017 growth trajectory of key segments of the cellular health screening market is described in detail in the report to provide readers with a clear picture of the granular composition of the market. The report segments the global cellular health screening market by test type and sample type in order to elucidate the various components of the global market. The geographical distribution of the global cellular health screening market is also studied in depth in the report to provide readers with pointers on which regions are likely to hold promising opportunities in the coming years.

By test type, the global cellular health screening market is segmented into telomere tests, oxidative stress tests, inflammation tests, heavy metal tests, and multi-test panels. The key sample types used for cellular health screening include blood and body fluids. Geographically, the global cellular health screening market is segmented into North America, Latin America, Europe, Asia Pacific except Japan, Japan, and the Middle East and Africa.

Global Cellular Health Screening Market: Competitive Dynamics

The report provides special attention to the competitive dynamics of the global cellular health screening market in order to help readers understand the ups and downs lying in store for them in the cellular health screening market in the coming years. The competitive strategies of leading players and their geographical presence is assessed in the report. Key companies profiled in the report include Quest Diagnostics Incorporated, Bio-Reference Laboratories Inc., Cell Science Systems Corporation, Cleveland HeartLab Inc., Genova Diagnostics Inc., Laboratory Corporation of America Holdings, Life Length S.L., and SpectraCell Laboratories Inc.


 
 
Back To Top